{"text": "indication amp rems perspective bmy will need to file sbla with full outreach dataset in future and this could differentiate liso cel breyanzi jcar017 and until then its just third to market undifferentiated car t"}
{"text": "bmy did publish pooled analysis transcend outreach pilot of 3 trials with around 60 patients that had outpatient administration and had promising results however larger n sizes are needed before fda will feel comfortable to view liso cel differently vs competition from an"}
{"text": "bmy nice to see a good trend right"}
{"text": "bmy new alert at stocks daytrading nyse nasdaq market 1813"}
{"text": "bmy new insider filing on bristol myers squibb co s director derica w rice"}
{"text": "bmy historical trades at play 9 4 9 23"}
